VITRO DIAGNOSTICS INC Contracts & Agreements

Form of Representatives Warrant (Filed With SEC on September 5, 2024)

Form of Underwriting Agreement (Filed With SEC on September 5, 2024)

Consolidated Note (Filed With SEC on July 22, 2024)

Target Agreement (Filed With SEC on July 22, 2024)

Amendment to 6% Unsecured Promissory Note (Filed With SEC on July 1, 2024)

Amendment to 4% Unsecured Promissory Note (Filed With SEC on July 1, 2024)

Letter Agreement, dated October 6, 2023, between the Company and Spartan (Filed With SEC on July 1, 2024)

Consulting Agreement (Filed With SEC on July 1, 2024)

Pre-funded Warrants (Filed With SEC on June 27, 2024)

Alchemy Amendment (Filed With SEC on June 27, 2024)

Target Agreement (Filed With SEC on June 27, 2024)

Lock-Up Agreement (Filed With SEC on June 27, 2024)

Form of Senior Secured Promissory Note (Filed With SEC on April 17, 2024)

Amendment to 6^ Unsecured Promissory Note (Filed With SEC on February 2, 2024)

Amendment to 4% Unsecured Promissory Note (Filed With SEC on February 2, 2024)

Letter Agreement, dated October 6, 2023, between the Company and Spartan (Filed With SEC on February 2, 2024)

Consulting Agreement (Filed With SEC on February 2, 2024)

Standstill Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 29, 2024)

Form of Warrant to Purchase Stock (Filed With SEC on January 29, 2024)

Description of Capital Stock (Filed With SEC on January 29, 2024)

Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 29, 2024)

Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 29, 2024)

Memorandum of Understanding, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 29, 2024)

Form of 8% Convertible Promissory Note (Filed With SEC on January 29, 2024)

Form of Convertible Note and Warrant Purchase Agreement (Filed With SEC on January 29, 2024)

Offer Letter (Filed With SEC on January 23, 2024)

Mutual Release (Filed With SEC on January 23, 2024)

Consulting Agreement (Filed With SEC on January 23, 2024)

Amendment to Engagement Agreement, dated October 4, 2023, between the Company and Bridgeway Capital Partners (Filed With SEC on December 12, 2023)

Letter Agreement, dated October 6, 2023, between the Company and Spartan (Filed With SEC on December 12, 2023)

Consulting Agreement (Filed With SEC on November 22, 2023)

Purchase Agreement (Filed With SEC on November 22, 2023)

Form of Senior Secured Promissory Note (Filed With SEC on November 22, 2023)

Form of Warrant (Filed With SEC on November 22, 2023)

Security Agreement (Filed With SEC on November 22, 2023)

Registration Rights Agreement (Filed With SEC on November 22, 2023)

Form of Representatives Warrant (Filed With SEC on July 17, 2023)

Form of Underwriting Agreement (including the form of Lock-Up Agreement) (Filed With SEC on July 17, 2023)

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement (Filed With SEC on June 29, 2023)

Form of Indemnification and Advancement Agreement for directors and officers (Filed With SEC on June 29, 2023)

Form of Warrant to Purchase Stock (Filed With SEC on April 20, 2023)

Memorandum of Understanding, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Form of 8% Convertible Promissory Note (Filed With SEC on January 30, 2023)

Form of Convertible Note and Warrant Purchase Agreement (Filed With SEC on January 30, 2023)

Standstill Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Description of Capital Stock (Filed With SEC on January 30, 2023)

Form of Warrant to Purchase Stock (Filed With SEC on January 30, 2023)

Executive Employment Agreement, dated December 1, 2020, between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Agreement and Plan of Exchange, dated August 1, 2021, by and among Infinivive MD, LLC, Jack Zamora, its Sole Member, and the Registrant (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated December 1, 2020, between the Registrant and James R. Musick (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated February 1, 2021, by and between the Registrant and Caroline Mosessian (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and Nathan Haas (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and Caroline Mosessian (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated August 1, 2021, by and between the Registrant and Nathan Haas (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated April 9, 2020, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated December 1, 2020, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated November 30, 2020, by and between the Registrant and James R. Musick (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated November 30, 2020, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated May 1, 2018, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated May 1, 2018, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Form of Non-Statutory Stock Option Grant Notice and Stock Option Agreement under the 2022 Incentive Award Plan (Filed With SEC on September 9, 2022)

Form of Incentive Stock Option Grant Notice and Stock Option Agreement under the 2022 Incentive Award Plan (Filed With SEC on September 9, 2022)

Amendment to the 2022 Equity Incentive Plan (Filed With SEC on September 9, 2022)

2022 Equity Incentive Plan (Filed With SEC on September 9, 2022)

Form of Stock Purchase Warrant B (Filed With SEC on September 9, 2022)

Form of Stock Purchase Warrant A (Filed With SEC on September 9, 2022)

Form of Common Stock Certificate (Filed With SEC on September 9, 2022)

Agreement and Plan of Merger, dated August 1, 2021, by and among Fitore, Inc., the Registrant, Vitro Acquisition Corp. No. 1 and the Fitore Stockholders named therein (Filed With SEC on September 9, 2022)

Consultant Agreement, dated October 1, 2021, by and between the Registrant and Innovative Strategies & Solutions, Inc (Filed With SEC on September 9, 2022)

Convertible Promissory Note, dated May 31, 2022, issued by the Registrant to Kevin Melling (Filed With SEC on September 9, 2022)

Note Purchase Agreement, dated May 31, 2022, by and between the Registrant and Kevin Melling (Filed With SEC on September 9, 2022)

Convertible Promissory Note, dated May 31, 2022, issued by the Registrant to Bruce Peterson (Filed With SEC on September 9, 2022)

Note Purchase Agreement, dated May 31, 2022, by and between the Registrant and Bruce Peterson (Filed With SEC on September 9, 2022)

Joint Development Agreement, dated May 15, 2018, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Amendment, dated April 28, 2022, to Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (Filed With SEC on September 9, 2022)

Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (Filed With SEC on September 9, 2022)

Joint Operating Agreement, dated July 14, 2020, by and between The Partners Stem Cell Centre (PSCC) Ltd. and the Registrant (Filed With SEC on September 9, 2022)

Subscription Agreement and 6% Unsecured Promissory Note Due December 31, 2025, dated November 1, 2020, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Subscription Agreement and 4% Unsecured Promissory Note Due December 31, 2025, dated November 1, 2020, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Lease Agreement, dated July 1, 2020, by and between Kokopelli Properties, LLC and the Registrant (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated November 30, 2020, by and between the Registrant and John Evans (Filed With SEC on September 9, 2022)

Addendum to Employment Agreement (Separation Agreement), dated February 19, 2021, by and between the Registrant and Keith Burge (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated December 2, 2020, by and between the Registrant and Keith Burge (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated October 1, 2021, by and between Nathan Haas and the Registrant (Filed With SEC on September 9, 2022)

Memorandum of Understanding (Filed With SEC on June 4, 2020)

STEM CELL LAB DEVELOPMENT AGREEMENT (Filed With SEC on July 11, 2017)

AMENDMENT TO MEMORANDUM OF UNDERSTANDING (Filed With SEC on April 19, 2017)

STEM CELL LAB DEVELOPMENT AGREEMENT (Filed With SEC on March 29, 2017)

MEMORANDUM OF UNDERSTANDING (Filed With SEC on March 29, 2017)

Rule 10b5-1 Sales Plan (Filed With SEC on August 19, 2009)

Category

Industry

Companies

Contracts

VITRO DIAGNOSTICS INC Contracts & Agreements